Full analysis of the scientific dosage and correct usage of perampanel tablets

The usage of perampanel tablets should be individually formulated based on the patient's condition, age, weight and concomitant medications. This medicine is generally taken orally once a day before going to bed. It can reduce the impact of drowsiness and dizziness on daytime activities.

For patients with epilepsy who are 12 years old and above, and who are not combined with enzyme inducer drugs (such as carbamazepine, phenytoin), the initial recommended dose is 2mg/day. Patients taking these inducer drugs can appropriately increase the initial dose or increase the dose more quickly due to accelerated metabolism of perampanel. When increasing the dosage, increase 2mg every 1 to 2 weeks until the maintenance dose is reached 4 - 12mg/ days.

The maximum recommended dose is12mg/day, but individual tolerance varies widely. Some patients have satisfactory efficacy with low doses (4 - 6mg/day). High doses have many side effects, so the pros and cons need to be weighed. Patients taking hepatic enzyme inducers may need higher maintenance doses, but adjustments must be made gradually.

It is recommended that patients with hepatic insufficiency (mild to moderate) use it at a reduced dosage, and patients with severe hepatic impairment should avoid its use. No dose adjustment is required in patients with renal insufficiency, but there are insufficient data in patients with end-stage renal disease and caution should be used.

Perampanel is not recommended for use in children under the age of 4 due to lack of sufficient safety data. Children and adolescent patients should be monitored for weight, behavioral changes, and growth and development.

If treatment is interrupted for more than one day, it is recommended to restart at the original dose. Do not stop the medication suddenly to avoid rebound seizures. Reduction or discontinuation of medication should be done slowly under the guidance of a doctor to prevent aggravation of epilepsy.

Reference materials:https://www.drugs.com/mtm/perampanel.html